Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactions
Numerous drug-drug interaction (DDI) trials have to be conducted in healthy volunteers based on current regulatory guidelines. Because the worst-case scenario of strong cytochrome P450 (CYP) inhibitors has to be tested, the results and their validity have to be balanced with the risk to volunteer sa...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
Journal of clinical pharmacology
Year: 2020, Jahrgang: 60, Heft: 10, Pages: 1294-1303 |
| ISSN: | 1552-4604 |
| DOI: | 10.1002/jcph.1622 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/jcph.1622 Verlag, kostenfrei, Volltext: https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.1622 
|
| Verfasserangaben: | Brit Silja Rohr and Gerd Mikus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1777449723 | ||
| 003 | DE-627 | ||
| 005 | 20230426124444.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211115s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jcph.1622 |2 doi | |
| 035 | |a (DE-627)1777449723 | ||
| 035 | |a (DE-599)KXP1777449723 | ||
| 035 | |a (OCoLC)1295680302 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rohr, Brit Silja |d 1995- |e VerfasserIn |0 (DE-588)1245826166 |0 (DE-627)1777449413 |4 aut | |
| 245 | 1 | 0 | |a Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactions |c Brit Silja Rohr and Gerd Mikus |
| 264 | 1 | |c 2020 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 21 May 2020 | ||
| 500 | |a Gesehen am 15.11.2021 | ||
| 520 | |a Numerous drug-drug interaction (DDI) trials have to be conducted in healthy volunteers based on current regulatory guidelines. Because the worst-case scenario of strong cytochrome P450 (CYP) inhibitors has to be tested, the results and their validity have to be balanced with the risk to volunteer safety. | ||
| 700 | 1 | |a Mikus, Gerd |e VerfasserIn |0 (DE-588)110903137 |0 (DE-627)691097941 |0 (DE-576)336988710 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical pharmacology |d Hoboken, NJ : Wiley, 1974 |g 60(2020), 10, Seite 1294-1303 |h Online-Ressource |w (DE-627)320484599 |w (DE-600)2010253-7 |w (DE-576)094752567 |x 1552-4604 |7 nnas |a Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactions |
| 773 | 1 | 8 | |g volume:60 |g year:2020 |g number:10 |g pages:1294-1303 |g extent:10 |a Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactions |
| 856 | 4 | 0 | |u https://doi.org/10.1002/jcph.1622 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.1622 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211115 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 110903137 |a Mikus, Gerd |m 110903137:Mikus, Gerd |d 910000 |d 910100 |d 50000 |e 910000PM110903137 |e 910100PM110903137 |e 50000PM110903137 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 |y j | ||
| 998 | |g 1245826166 |a Rohr, Brit Silja |m 1245826166:Rohr, Brit Silja |d 50000 |e 50000PR1245826166 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1777449723 |e 4002203476 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["First published: 21 May 2020","Gesehen am 15.11.2021"],"recId":"1777449723","language":["eng"],"title":[{"title_sort":"Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactions","title":"Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactions"}],"person":[{"given":"Brit Silja","family":"Rohr","role":"aut","display":"Rohr, Brit Silja","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Mikus, Gerd","role":"aut","family":"Mikus","given":"Gerd"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"title_sort":"Journal of clinical pharmacology","title":"Journal of clinical pharmacology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.11.24"],"disp":"Proposal of a safe and effective study design for CYP3A-mediated drug-drug interactionsJournal of clinical pharmacology","language":["eng"],"recId":"320484599","pubHistory":["Volume 14, issue 1 (1974)-"],"part":{"year":"2020","pages":"1294-1303","issue":"10","volume":"60","text":"60(2020), 10, Seite 1294-1303","extent":"10"},"name":{"displayForm":["publ. in association with the American College of Clinical Pharmacology"]},"origin":[{"publisher":"Wiley ; Sage","dateIssuedKey":"1974","dateIssuedDisp":"1974-","publisherPlace":"Hoboken, NJ ; Thousand Oaks [u.a.]"}],"id":{"zdb":["2010253-7"],"doi":["10.1002/(ISSN)1552-4604"],"eki":["320484599"],"issn":["1552-4604"]},"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"2020"}],"id":{"eki":["1777449723"],"doi":["10.1002/jcph.1622"]},"name":{"displayForm":["Brit Silja Rohr and Gerd Mikus"]}} | ||
| SRT | |a ROHRBRITSIPROPOSALOF2020 | ||